lifestyle.ebusinessplanet.com

Author: Elanco Animal Health

Elanco’s Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock

April 27, 2026
Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement

April 16, 2026
Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*

April 9, 2026
Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results

March 10, 2026
Elanco to Participate in Upcoming Investor Conferences

March 9, 2026
Elanco Announces Updates to Board of Directors

March 9, 2026
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement

January 23, 2026
Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference

January 6, 2026
Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis

December 31, 2025
Elanco’s Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs

December 18, 2025